Synthetic Biologics Announces Extension of Compliance Plan Period by NYSE American
The Pharma Data
NOVEMBER 23, 2020
On February 7, 2020 the NYSE American notified the Company that it accepted the Company’s plan to regain compliance before November 25, 2020 , the end of the compliance plan period. This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Let's personalize your content